首页> 外文OA文献 >Aspects on the role of prophylactic procedures to influence post-ERCP complication rates
【2h】

Aspects on the role of prophylactic procedures to influence post-ERCP complication rates

机译:预防程序对ERCP术后并发症发生率的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: When the technique to use ERCP was introduced almost fifty years ago, themorbidity in treatment of hepato-biliary diseases decreased due to the introduction of this miniinvasivemodality, reducing the need for open surgical procedures. However, ERCP proceduresare still marred with complications such as pancreatitis, cholangitis, hemorrhage andperforation and every measure must be undertaken to reduce these adverse events. Objectives: The hypotheses of this thesis were: 1) Prophylactic antibiotics in ERCP do notreduce the complication rates enough to recommend it generally. 2) Prophylactic pancreaticstents reduce the PEP risk more the larger they are. 3) A grading scale for the complexity of theERCP procedure (HOUSE) was validated in relation to success-rates, complications and durationof the procedure. 4) Preoperative SEMS in periampullary tumors show less bacterialcontamination in intraoperatively collected bile than plastic stents, thereby reducingperioperative complications. Methods: In the first study all ERCPs, included in GallRiks between May 2005 and June 2013,were studied regarding complication rates in relation to prophylactic antibiotics. Further, in thesecond paper, all ERCPs between 2006 and 2014 where an accidental pancreatic cannulationoccurred and a prophylactic pancreatic stent was used were investigated, determinating howthe diameter and length of the stent affected the adverse events. In the third study, an ERCPcomplexity classification, (HOUSE), was validated in relation to success-rates, complications andduration of the procedure. The final study, an RCT compared preoperative SEMS to plastic stentsin resectable periampullary tumors regarding intraoperative bacterial, histopathological andsurgical technical findings as well as perioperative complications. Results: In the first study complications were studied in relation to prophylactic antibiotics. Wefound a reduction of 26 % of OR in overall complications if prophylactic antibiotics were given,but in absolute figures reduction of the risk was a modest 2.6% and the NNT 38 patients to avoidone complication. In our second study an almost fourfold OR elevation (OR 3.58) in complicationrates was seen if prophylactic pancreatic stents with a diameter ≤5 Fr were used compared tostents >5 Fr, the complication rates were further lowered (1.4 %) if the stents were >5 cm. Thethird paper validated a new three-graded ERCP complexity grading scale (HOUSE) in relation tosuccess and complication rates, demonstrating a doubled PEP rate in HOUSE 2 and 3 (7.0 % and6.8 %) compared to class 1 (3.4%) and longer procedure times, the higher the HOUSE class(HOUSE 1, 40 min; 2, 65 min; and 3, 106 min). In the final study, comparing preoperative SEMSto plastic stents in resectable periampullary tumors, higher preoperative stent dysfunction rateswere found among the plastic stents (19 % vs 0 %, p=0.03). Intraoperatively, no differenceswere seen in bacterial occurrence in collected bile or in operative technical difficulties, but ahigher histopathological foreign body reaction (sinus histiocytos) in lymph nodes in the hepatoduodenalligament in the plastic stent group. Also, the overall postoperative complication rateswere increased in the group where plastic stents were used (72 % vs 52 %), as were thefrequency of anastomotic leakages (12 % vs 3.7 %), but none of these postoperativecomplications reached statistical significance. Conclusion: Prophylactic antibiotics in ERCP lower the overall complication rates but notsufficiently to recommend this as prophylaxis in every ERCP procedure. On the contrary,prophylactic pancreatic stents could be used more frequently in ERCP and larger diameters andlonger stents demonstrated lower complications rates. We also launched an ERCP complexitygrading scale (HOUSE) and validated it in relation to complication rates and procedure duration.Finally, we demonstrated that SEMS could be used in resectable periampullary tumors andfound no differences in bacterial growth in intraoperatively collected bile but a lowerpreoperative stent dysfunction rate if SEMS were used. Neither did we find any intraoperativetechnical downsides when using SEMS, or any disadvantages in postoperative complicationrates.
机译:背景:大约50年前引入使用ERCP的技术时,由于引入了这种微创方式,降低了治疗肝胆疾病的发病率,从而减少了开放手术的需要。但是,ERCP手术仍然伴有胰腺炎,胆管炎,出血和穿孔等并发症,必须采取一切措施以减少这些不良事件。目的:本文的假设是:1)ERCP中的预防性抗生素不能降低并发症的发生率,因此不能普遍推荐使用。 2)预防性胰腺癌越大,降低的PEP风险越大。 3)验证了ERCP程序(HOUSE)复杂性的等级量表,该程序涉及成功率,并发症和程序持续时间。 4)壶腹周围肿瘤的术前SEMS术中收集的胆汁中的细菌污染比塑料支架少,从而减少了围手术期并发症。方法:在第一项研究中,研究了2005年5月至2013年6月间GallRik中包括的所有ERCP,研究了与预防性抗生素相关的并发症发生率。此外,在第二篇论文中,研究了2006年至2014年间所有发生了意外胰管插管并使用了预防性胰腺支架的ERCP,以确定支架的直径和长度如何影响不良事件。在第三项研究中,验证了ERCP复杂度分类(HOUSE)与成功率,并发症和手术持续时间有关。在一项最终研究中,一项RCT在术中细菌,组织病理学和外科技术发现以及术中并发症方面比较了可切除壶腹周围肿瘤中术前SEMS与塑料支架的比较。结果:在第一项研究中,研究了与预防性抗生素相关的并发症。我们发现,如果给予预防性抗生素,总体并发症的OR降低了26%,但从绝对数字上,该风险降低了2.6%,而NNT避免了38例并发症。在我们的第二项研究中,如果使用直径≤5Fr的预防性胰腺支架,而支架> 5 Fr,则并发症发生率几乎提高了四倍(OR 3.58),如果支架> 5 Fr,并发症发生率进一步降低(1.4%) 5厘米第三篇论文验证了与成功率和并发症发生率相关的新的三级ERCP复杂度分级量表(HOUSE),表明HOUSE 2和3中的PEP率翻了一番(7.0%和6.8%),而1类(3.4%)及更长程序时间越多,HOUSE班级越高(HOUSE 1、40分钟,2、65分钟和3、106分钟)。在最后的研究中,比较了可手术的壶腹周围肿瘤中术前SEMS与塑料支架的比较,发现塑料支架中术前支架功能障碍的发生率更高(19%vs 0%,p = 0.03)。术中,在收集的胆汁中的细菌发生率或手术技术困难方面未见差异,但在塑料支架组中,肝十二指肠外淋巴结的淋巴结组织病理学异物反应(窦性组织细胞)更高。同样,使用塑料支架的组的总体术后并发症发生率增加(72%vs 52%),吻合口漏发生率也增加(12%vs 3.7%),但这些术后并发症均未达到统计学意义。结论:ERCP中的预防性抗生素可降低总体并发症发生率,但不足以在每次ERCP手术中推荐作为预防措施。相反,预防性胰支架可以更频繁地用于ERCP中,并且直径更大,支架更长表明并发症发生率更低。我们还启动了ERCP复杂性分级量表(HOUSE)并在并发症发生率和手术时间方面进行了验证。最后,我们证明了SEMS可用于可切除的壶腹周围肿瘤,并且在术中收集的胆汁中细菌生长没有差异,但术前支架功能低下使用SEMS时的费率。使用SEMS时,我们也没有发现任何术中技术方面的缺点,也没有发现术后并发症的任何缺点。

著录项

  • 作者

    Olsson, Greger;

  • 作者单位
  • 年度 2017
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号